Cannabis Central: Pure-Play Pot Stock Index Continued To Advance This Past Week

The munKNEE Pure-Play Pot Stock Index was up 2.4% for the week ending December 18th compared to +4.1% the previous week. 11 of the 25 constituents went DOWN and 14 went UP but only 3 changed price by 10% or more. In addition, all 3 of the index categories went UP in price. The details are as follows:

Index Performance

The constituents in the Index operate in 3 categories based on their primary area of focus in the cannabis industry and the constituents within each category are identified below with how each of the categories did along with those stocks within each category that changed price by 5% or more:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category went up 2.4% vs. - 3.9% the previous week (see here). The category consists of  22 index constituents that grow, process, and sell cannabis and hemp flower and related products.
   • The Canadian Licensed Producer (LPs) Sub-Category went down 0.6% with only 1 of the 7 constituents within the category changing price by 10% or more, namely:
     1. Tilray (TLRY) +14.4%
   • The U.S. Non-Hemp Multi-State Operator (MSOs) Sub-Category went down 4.3% with only 2 of the 13 index constituents in the category changing price by 10% or more, as follows:
     1. Medicine Man (SHWZ) +19.4%
     2. Jushi (JUSHF) +10.8%
   • The Hemp Seed-to-Sale MSO Sub-Category went down 6.3% but neither of the index constituents in the category went down by 10% or more.
2. The Extraction Category went up 1.7%, This category focuses on the extraction of cannabis compounds and their infusion into consumer products, but neither of the index constituents in the category went down by 10% or more.
3. The Consumption Devices Category went up 6.6%. This category has only one index constituent, Greenlane (GNLN), which is focused on developing and selling personal consumption devices for cannabis consumers, such as vape pens and inhalers.

Further details regarding the equal-weighted munKNEE Pure-Play Pot Stock Index are as follows:

• The 25 pure-play constituents in the Index are just that, pure, deriving 100% of their revenue from the sale of cannabis or cannabis-related products.
  • Unlike every marijuana ETF and every other cannabis tracking index, the Index excludes "wanna-be" companies that currently generate little, if any, of their total revenue from the cannabis industry so as to reflect the true health of the marijuana industry in the U.S. and Canada.
  • The average market capitalization of the 25 constituents in the Index is US$1.5B.
    • 10 constituents have market caps ranging between $1.0B and $10.0B;
    • 4 have market caps between $500M and $999M and
    • 11 constituents have market caps ranging between $100M and $499M